RE:Quote for the lazy............Looks like they are assembling a quality team to navigate the difficult waters of a corporate restructuring.
Quality track record for both individuals with strong background in finance and generics at Teva and Forrest Labs. The outlook is good - but not for holders of the existing common stock. If we see insider purchasing, I may be convinced otherwise.
Looking forward to a quality restructured Concordia 2.0